Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine
- 1 February 1997
- journal article
- research article
- Published by Elsevier in Transplantation Proceedings
- Vol. 29 (1-2) , 733-734
- https://doi.org/10.1016/s0041-1345(96)00443-5
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Acute graft-versus-host disease: grade and outcome in patients with chronic myelogenous leukemia. Working Party Chronic Leukemia of the European Group for Blood and Marrow TransplantationBlood, 1995
- Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia?Blood, 1993
- LONG-TERM CYCLOSPORIN THERAPY MAY DECREASE THE RISK OF CHRONIC GRAFT-VERSUS-HOST DISEASEBritish Journal of Haematology, 1990
- Methotrexate and Cyclosporine Compared with Cyclosporine Alone for Prophylaxis of Acute Graft versus Host Disease after Marrow Transplantation for LeukemiaNew England Journal of Medicine, 1986
- Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppressionBlood, 1981
- Antileukemic Effect of Graft-versus-Host Disease in Human Recipients of Allogeneic-Marrow GraftsNew England Journal of Medicine, 1979
- Regression Models and Life-TablesJournal of the Royal Statistical Society Series B: Statistical Methodology, 1972
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958